HOME >> BIOLOGY >> NEWS
Women who drink may be at greater risk of cardiovascular complications than men

  • Chronic, heavy alcohol consumption can increase the prevalence of cardiovascular complications, including hypertension, cardiomyopathy, arrhythmia, and stroke.
  • Some female alcoholics experience more severe cardiovascular effects from heavy drinking than male alcoholics; these effects are noted earlier and at lower consumption levels than those noted in men.
  • Women who drink chronically may also be at risk for future cardiovascular complications.

The cardiovascular effects of chronic, heavy alcohol consumption can include an increased prevalence of hypertension, cardiomyopathy, arrhythmia, and stroke. Most of the studies to date, however, have focused on males, even though women appear to be more sensitive than men to alcohol's toxic effects on the heart. Research published in the September issue of Alcoholism: Clinical & Experimental Research confirms that some female alcoholics experience more severe cardiovascular effects from heavy alcohol drinking than those observed in male alcoholics, and these effects are noted at an earlier stage of drinking and at a lower consumption level than those noted in men.

"This work adds to the growing body of literature that confirms what many researchers in the field have suspected," said Nancy C. Bernardy, a research psychologist at the National Center for PTSD in White River Junction, Vermont. "The use of drugs, such as alcohol and nicotine, has a greater adverse impact on women than on men."

This phenomenon - where women need to drink a lesser amount of alcohol than men do, or for a shorter amount of time, to produce the same degree of damage - is referred to as "telescoping."

"Additionally," said Bernardy, also the first author of the study, "I think that this work adds to growing evidence that there are subtle differences in the cardiovascular systems of women in general compared to those of men. Women's hearts are not just smaller versions of men's.
'"/>


14-Sep-2003


Page: 1 2 3

Related biology news :

1. Women who have donated eggs sought for national study
2. Donaghue Womens Health Investigator Program awards grants to three at Yale
3. Top Houston Women in Technology honoree at UH
4. Marie Curie Nobel Centennial Celebration of Women in Science
5. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Women are more likely to suffer recurrent miscarriages if their first child is a boy
8. Womens health issues, child and adolescent disorders featured at APAs annual meeting
9. Women who marry alcoholics
10. Pregnancy hormone induces healthy blood vessels, Magee-Womens Research Institute scientists report
11. US Women scientists from Latin America to encourage colleagues from south

Post Your Comments:
(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, a ... with specialties in single use solutions, headquartered in ... Inc. (a California corporation with locations ... San Jose, Costa Rica ). This ... Rica with ATL Technology,s existing facility in ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
(Date:7/3/2015)... Forskare kan ansöka ... http://www.openinnovationinscience.at till det återkommande utbildningsprogrammet "Lab ... i Wien .  ... forskare och vetenskapsmän som genomfördes av Ludwig ... utmaningar bristen på incitament för att undersöka ...
(Date:7/2/2015)... GLEN ELLYN, Ill. , July 2, 2015 /PRNewswire-USNewswire/ ... and Colton Eakins are gaining invaluable real-world ... Institute of Technology this summer. The students ... Dr. Jeff Wereszczynski,s research group at IIT. ... Professors Dr. Tom Carter , Physics; Dr. ...
(Date:7/1/2015)... ... 2015 , ... It is now possible to separate two common disorders: post-traumatic ... tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, and ... is believed to be the largest brain imaging study ever, will be published on ...
(Date:7/1/2015)... 2015   Neuraltus Pharmaceuticals, Inc. , a privately-held ... drugs to treat neurodegenerative diseases such as amyotrophic ... G. Miller , M.D., Director of the Forbes Norris ... Medical Center in San Francisco, has been awarded a ... to help fund a Phase 2 clinical study ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3COD Students Participate in Prestigious Summer Internships 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
Cached News: